The use of molecular markers of bone turnover in the management of patients with metastatic bone disease (Q36990793)

17 August 2017

1 reference

title

The use of molecular markers of bone turnover in the management of patients with metastatic bone disease (English)

1 reference

17 August 2017

Markus J Seibel

1 reference

17 August 2017

publication date

2 November 2007

1 reference

17 August 2017

published in

Clinical Endocrinology

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

839-849

1 reference

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Crosstalk between cancer cells and bone microenvironment in bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Biochemical markers of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Correlation of urine type I collagen-cross-linked N telopeptide levels with bone scintigraphic results in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Follow-up of collagen crosslink excretion in patients with oral squamous cell carcinoma and analysis of tissue samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Pyridinium crosslinks as markers of bone resorption in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Usefulness of bone markers for detection of bone metastases in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Pyridinoline cross‐links as markers for primary and secondary bone tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Bone remodeling markers in the detection of bone metastases in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Expression of bone sialoprotein in primary human breast cancer is associated with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. European Organization for Research and Treatment of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Serum amino-terminal propeptide of type 1 procollagen (P1NP) in prostate cancer: a potential predictor of bone metastases and prognosticator for disease progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Bone resorption predicts for skeletal complications in metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Biochemical markers of bone turnover in women with surgically treated carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: effects of glucocorticoid therapy and disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03112.X

10.1111/J.1365-2265.2007.03112.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference